Institute for International Research

Strategies to Manage Oncology Pharmaceuticals - Providing Best Affordable Options for Patients

Schedule:
8:30 Workshop Registration 9:00 Workshop Begins 11:00 30 Minute Break
12:30-1:30 Luncheon 2:30 15 Minute Break 3:30 Workshop Concludes

Managing the costs of oncology drugs is critical in managing an effective specialty pharmaceutical program. The rising costs of oncology drugs are alarming and payors are seeking effective methods for controlling costs while assuring that quality care is being provided to their members. Physicians are striving to provide efficient, cost-effective care to their patients while maintaining financial stability. Payors and providers don't have effective forums for communication, and this workshop will provide an opportunity for discussion between both groups. In this session you will hear from executives from McKesson Specialty Oncology Services, McKesson Specialty Pharmacy Services, and an oncologist who will present solutions and lead a discussion with payors in the audience. Innovative solutions, including challenges and benefits, will be presented.

• The following topics will be presented:

  • Overview of community oncology market
    • Landscape of the past, present and future
    • Chemotherapeutic drugs, pipeline and trends
      • Oral therapy
      • Targeted therapy
    • Supportive care
    • Off-label use of drugs
  • Delivering efficient, high quality care in oncology
    • Use of standards of care, treatment guidelines and analytic tools
    • Pay for Performance
    • Metrics for measuring performance
    • Role of care management
    • Future role of technology and data
  • Challenges facing providers
    • Case study: Breast Cancer
    • Description of challenges
    • Realistic reimbursement strategies
  • Cost management strategies
    • Framework for collaboration between providers and payors
    • Payor preferred supplier agreements
    • Cost analysis strategies to evaluate chemotherapy regimens and supportive care
  • Panel Discussion

  Who Should Attend?

  Health plan executives responsible for drug spend under medical or pharmacy benefits, provider contracting, utilization review, care management, ancillary services and specialty drug distribution networks.

  About the Workshop Leaders

  Edward R. Arrowsmith, MD, MPH, Medical Oncologist and Director of Research, CHATTANOOGA ONCOLOGY & HEMATOLOGY ASSOCIATES
  

  Inga Aksamit, RN, MBA, OCN, Vice President, Clinical Services, MCKESSON SPECIALTY ONCOLOGY SERVICES
  

  Julie Wilson Ganz, PharmD, Director Clinical Services, MCKESSON SPECIALTY ONCOLOGY SERVICES
  
  Donald J. Vidic, RPh, MBA, Vice President, Operations, MCKESSON SPECIALTY ONCOLOGY SERVICES